Connect with us

Technology

Hospital PMI® at 55.8%; June 2024 Hospital ISM® Report On Business®

Published

on

TEMPE, Ariz., July 5, 2024 /PRNewswire/ — Economic activity in the hospital subsector grew in June for the 10th consecutive month after contracting twice in the previous four-month period, with 35 consecutive months of growth prior to that, say the nation’s hospital supply executives in the latest Hospital ISM® Report On Business®.

The report was issued today by Nancy LeMaster, MBA, Chair of the Institute for Supply Management® (ISM®) Hospital Business Survey Committee: “The Hospital PMI® registered 55.8 percent in June, a 2.6-percentage point decrease from the May reading of 58.4 percent, indicating a 10th consecutive month of growth after a contraction in August. The Business Activity Index expanded for the 10th consecutive month. The New Orders Index expanded for the 10th straight month, and the Employment Index remained in growth territory. The Supplier Deliveries Index remained in expansion (which indicates slower delivery performance). The Case Mix Index expanded in June, registering 51 percent, a decrease of 0.5 percentage point compared to the previous month’s figure of 51.5 percent. The Days Payable Outstanding Index remained in expansion territory in June, registering 51.5 percent, down 5.5 percentage points from the 57 percent reported in May. The Technology Spend Index reading of 61.5 percent is an increase of 1 percentage point compared to the 60.5 percent recorded in May. The Touchless Orders Index was ‘unchanged’ in June, registering 50 percent, up 1.5 percentage points from the 48.5 percent reported in May.”

LeMaster continues, “The majority of Business Survey Committee respondents indicated that patient volumes in June were strong — just not as strong as in May. Some panelists commented that their facilities experienced a shift to more medical versus surgical patients, while others noted elevated levels of surgeries and outpatient volumes. The Employment Index continued to indicate growth, with respondents crediting successful recruitment efforts and a reduction in turnover. To preserve margins, hospitals continued to focus on (1) replacing agency labor with permanent staff to reduce labor costs and (2) reducing utilization and increasing standardization of supplies. Weather impacted supply deliveries in parts of the country, and the syringe shortage continues to be problematic.”

Hospital PMI® History

Month

Hospital PMI®

Month

Hospital PMI®

Jun 2024

55.8

Dec 2023

62.5

May 2024

58.4

Nov 2023

59.8

Apr 2024

53.5

Oct 2023

52.1

Mar 2024

52.3

Sep 2023

57.0

Feb 2024

56.6

Aug 2023

47.5

Jan 2024

61.5

Jul 2023

53.3

Average for 12 months – 55.9

High – 62.5

Low – 47.5

 

About This Report
The information compiled in this report is for the month of June 2024.

The Hospital PMI® was developed in collaboration with the Association for Health Care Resource & Materials Management (AHRMM), an association for the health care supply chain profession, and a professional membership group of the American Hospital Association (AHA).

The data presented herein is obtained from a survey of hospital supply executives based on information they have collected within their respective organizations. ISM® makes no representation, other than that stated within this release, regarding the individual company data collection procedures. The data should be compared to all other economic data sources when used in decision-making.

Data and Method of Presentation
The Hospital ISM® Report On Business® is based on data compiled from hospital purchasing and supply executives nationwide. Survey responses reflect the change, if any, in the current month compared to the previous month. For each of the indicators measured (Business Activity, New Orders, Employment, Supplier Deliveries, Inventories, Prices, Prices: Pharmaceuticals, Prices: Supplies, Backlog of Orders, Imports, Inventory Sentiment, Case Mix, Days Payable Outstanding, Technology Spend, and Touchless Orders), this report shows the percentage reporting each response and the diffusion index. Responses represent raw data and are never changed. Beginning in January 2021, the Report On Business® staff and consultants are gathering market information to better validate the Exports Index. Exports Index data are still being collected.

The Hospital PMI® is a composite index computed from the following, equally weighted indexes: Business Activity, New Orders, Employment and Supplier Deliveries. Diffusion indexes have the properties of leading indicators and are convenient summary measures showing the prevailing direction of change and the scope of change. A Hospital PMI® index reading above 50 percent indicates that the hospital sub-sector is generally expanding; below 50 percent indicates that it is generally declining. For the sub-indexes, except Supplier Deliveries, an index reading above 50 percent indicates that the sub-index is generally expanding; below 50 percent indicates that it is generally contracting. A Supplier Deliveries Index above 50 percent indicates slower deliveries and below 50 percent indicates faster deliveries.

The Hospital ISM® Report On Business® survey is sent out to the Hospital Business Survey Committee respondents the first part of each month. Respondents are asked to ONLY report on U.S. operations for the current month. ISM® receives survey responses throughout most of any given month, with the majority of respondents generally waiting until late in the month to submit responses to give the most accurate picture of current business activity. ISM® then compiles the report for release on the fifth business day of the following month.

ISM ROB Content
The Institute for Supply Management® (“ISM”) Report On Business® (Manufacturing, Services, and Hospital reports) (“ISM ROB”) contains information, text, files, images, video, sounds, musical works, works of authorship, applications, and any other materials or content (collectively, “Content”) of ISM (“ISM ROB Content”). ISM ROB Content is protected by copyright, trademark, trade secret, and other laws, and as between you and ISM, ISM owns and retains all rights in the ISM ROB Content. ISM hereby grants you a limited, revocable, nonsublicensable license to access and display on your individual device the ISM ROB Content (excluding any software code) solely for your personal, non-commercial use. The ISM ROB Content shall also contain Content of users and other ISM licensors. Except as provided herein or as explicitly allowed in writing by ISM, you shall not copy, download, stream, capture, reproduce, duplicate, archive, upload, modify, translate, publish, broadcast, transmit, retransmit, distribute, perform, display, sell, or otherwise use any ISM ROB Content.

Except as explicitly and expressly permitted by ISM, you are strictly prohibited from creating works or materials (including, but not limited to tables, charts, data streams, time-series variables, fonts, icons, link buttons, wallpaper, desktop themes, online postcards, montages, mashups and similar videos, greeting cards, and unlicensed merchandise) that derive from or are based on the ISM ROB Content. This prohibition applies regardless of whether the derivative works or materials are sold, bartered, or given away. You shall not either directly or through the use of any device, software, internet site, web-based service, or other means remove, alter, bypass, avoid, interfere with, or circumvent any copyright, trademark, or other proprietary notices marked on the Content or any digital rights management mechanism, device, or other content protection or access control measure associated with the Content including geo-filtering mechanisms. Without prior written authorization from ISM, you shall not build a business utilizing the Content, whether or not for profit.

You shall not create, recreate, distribute, incorporate in other work, or advertise an index of any portion of the Content unless you receive prior written authorization from ISM. Requests for permission to reproduce or distribute ISM ROB Content can be made by contacting Rose Marie Goupil in writing at: ISM Research, Institute for Supply Management, 309 W. Elliot Road, Suite 113, Tempe, AZ 85284-1556, or by emailing rgoupil@ismworld.org; Subject: Content Request.

ISM shall not have any liability, duty, or obligation for or relating to the ISM ROB Content or other information contained herein, any errors, inaccuracies, omissions or delays in providing any ISM ROB Content, or for any actions taken in reliance thereon. In no event shall ISM be liable for any special, incidental, or consequential damages, arising out of the use of the ISM ROB. Report On Business®, PMI®, Manufacturing PMI®, Services PMI®, and Hospital PMI® are registered trademarks and trademarks of Institute for Supply Management®. Institute for Supply Management® and ISM® are registered trademarks of Institute for Supply Management, Inc.

About Institute for Supply Management®
Institute for Supply Management® (ISM®) is the first and leading not-for-profit professional supply management organization worldwide. Its community of more than 50,000 in more than 100 countries manage about US$1 trillion in corporate and government supply chain procurement annually. Founded in 1915 by practitioners, ISM is committed to advancing the practice of supply management to drive value and competitive advantage for its members, contributing to a prosperous and sustainable world. ISM empowers and leads the profession through the ISM® Report On Business®, its highly-regarded certification and training programs, corporate services, events, and assessments. The ISM® Report On Business®, Manufacturing, Services, and Hospital, are three of the most reliable economic indicators available, providing guidance to supply management professionals, economists, analysts, and government and business leaders. For more information, please visit: www.ismworld.org.

The text version of the public Hospital ISM® Report On Business® is posted on ISM®’s website at www.ismrob.org on the fifth business day* of every month at 10:00 a.m. ET.

The next Hospital ISM® Report On Business® featuring July 2024 data will be released at 10:00 a.m. ET on Wednesday, August 7, 2024.

*Unless the New York Stock Exchange is closed.

Contact: 

Rose Marie Goupil

Report On Business® Analyst

ISM®, ROB/Program Manager

Tempe, Arizona

+1 480.752.6276, ext. 3005

Email: rgoupil@ismworld.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/hospital-pmi-at-55-8-june-2024-hospital-ism-report-on-business-302189179.html

SOURCE Institute for Supply Management

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Waystar Announces Amendment to Its Credit Facilities

Published

on

By

Enhancements expected to boost flexibility and lower borrowing costs

LEHI, Utah and LOUISVILLE, Ky., Dec. 30, 2024 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced an amendment to its first lien credit agreement (the “amended credit agreement”) with its lenders. The amendment reprices Waystar’s term loan and increases its revolving credit facility.

Under the amended agreement, the term loan will now carry a reduced interest rate of adjusted SOFR +2.25%, down from the previous interest rate of adjusted SOFR +2.75%. In addition, Waystar will increase its revolving credit facility borrowing capacity to $400 million, up from $342.5 million, and lower the interest rate to adjusted SOFR +1.75%, compared to the previous interest rate of adjusted SOFR +2.25%. These changes are expected to reduce borrowing costs and generate interest expense savings for the company.

The amendments follow Waystar’s successful initial public offering on June 7, 2024, with net proceeds used to reduce debt, as well as an earlier loan repricing on June 27, 2024.

Additional details about the amended credit agreement are available in Waystar’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 30, 2024. The filing is available on the investor relations page of Waystar’s website at investors.waystar.com.

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, future borrowing costs, interest expense savings, and the impact of the amended credit agreement. Forward-looking statements include all statements that are not historical facts. These statements may include words such as “believe,” “could,” “expect,” “may,” “potential,” “predict,” “project,” “future,” “will,” the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release.

The forward-looking statements contained in this press release are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our ability to successfully execute on our business strategies in order to grow; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of “Risk Factors” in the Company’s prospectus filed with the Securities and Exchange Commission (the “SEC”) on June 7, 2024 and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

About Waystar
Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar’s enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Investor Contact
Sandy Draper
investors@waystar.com

Media Contact
Kristin Lee
kristin.lee@waystar.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-announces-amendment-to-its-credit-facilities-302340397.html

SOURCE Waystar

Continue Reading

Technology

SWEP Opens Large Scale Propane Testing Facility

Published

on

By

DOWNERS GROVE, Ill., Dec. 30, 2024 /PRNewswire/ — SWEP, part of Dover (NYSE: DOV) and a world-leading supplier of brazed plate heat exchangers (BPHEs), today announced the opening of a new rig for propane testing at the SWEP Research & Development Center in Landskrona, Sweden.

Recent policies such as the European F-Gas Regulation are driving market demand for heating and cooling systems that operate with natural- or low-GWP refrigerants. The capability to run large scale propane testing is an important step for SWEP to meet current and future need for sustainable heat transfer solutions. The heating and cooling sector (HVAC) accounts for a significant share of global energy consumption, and the industry is challenged to find innovations to accelerate decarbonization.

“The new test rig will be crucial in the development of brazed plate heat exchangers that are optimized for systems based on natural refrigerants. We are working closely with our customers to create products that meet system design requirements of next-generation heat pumps and chillers,” says Ulrika Nordqvist, SWEP President.

SWEP has been able to test small- and medium-sized units with propane since 2019, and the new rig will now enable in-house testing of up to XL-size units.

“The new test rig is optimized for a wide propane envelope and will be instrumental in the ongoing development of highly efficient and safe heat transfer solutions. We will continue to support our customers in the transition towards more sustainable heating and cooling systems,” says Fabienne Bourquenoud Moret, VP of Marketing, Research & Development at SWEP.

Although propane gas has a low GWP, its flammable properties make it hazardous to handle in a test environment. Ensuring operational safety and quality has been central in the launch of the new rig, which is part of SWEP’s Global Investment Program. Running from 2019 through 2025, the program seeks to strengthen SWEP’s long-term capacity and add new capabilities to help ensure customer success and accelerate growth.

About SWEP:
At SWEP, we believe our future rests on giving more energy than we take – from our planet and our people. That’s why we pour our energy into leading the conversion to sustainable energy usage in heat transfer. Over three decades, the SWEP brand has become synonymous with challenging efficiency.

SWEP is a world-leading supplier of brazed plate heat exchangers for HVAC and industrial applications. With over 1,100 dedicated employees, carefully selected business partners, and a global presence with production, sales, and dedicated service, we bring a level of expertise and closeness to our customers that’s redefining competitive edge in a more sustainable future. SWEP is part of Dover Corporation, a multi-billion-dollar, diversified manufacturer of a wide range of proprietary products and components for industrial and commercial use.

About Dover:
Dover is a diversified global manufacturer and solutions provider with annual revenue of over $7 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of over 24,000 employees takes an ownership mindset, collaborating with customers to redefine what’s possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under “DOV.” Additional information is available at dovercorporation.com.   

SWEP Contact: 
Malin Bengtsson
+46 418 400 720
malin.bengtsson@swep.net 

Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com

Dover Investor Contact:
Jack Dickens, VP, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/swep-opens-large-scale-propane-testing-facility-302340339.html

SOURCE Dover

Continue Reading

Technology

SIGMA LITHIUM EXCEEDS 4Q2024 TARGETS WITH 75,000T OF QUINTUPLE ZERO GREEN LITHIUM PRODUCED; POSITIONED TO SURPASS 270,000T IN 2025

Published

on

By

SÃO PAULO, Dec. 30, 2024 /PRNewswire/ — Sigma Lithium Corporation (TSXV/NASDAQ: SGML, BVMF: S2GM34) (“Sigma Lithium” or the “Company”), a leading global lithium producer dedicated to powering the next generation of electric vehicles with carbon-neutral, socially and environmentally sustainable lithium concentrate (“Quintuple Zero Green Lithium”), is pleased to announce the successful completion of the 2024 business year, significantly exceeding fourth-quarter production target with approximately 75,000 tonnes produced, and achieving a total of approximately 240,000 tonnes in production and sales volumes for the year. With its strong operational performance and commitment to sustainable growth, Sigma Lithium is well-positioned to exceed its 2025 production target of 270,000 tonnes.

Ana Cabral, CEO and Co-Chairman of Sigma Lithium, said, “With the successful completion of the fourth quarter, we are demonstrating mastery of our innovative green industrialization technologies for lithium processing and dense media separation. Our Greentech Industrial Plant is delivering lithium materials that are aligned with the ethos of the consumers of the electric vehicles, and this gives our team a tremendous sense of purpose and accomplishment. Exceeding production and commercial targets in the fourth quarter has reinforced our confidence in our ability to surpass our 2025 production targets. This remarkable year is a testament to the relentless pursuit of excellence by a highly dedicated team, showing that innovation thrives in diverse work environments”.

She added: “We are also deeply honored by the embrace and support we have received throughout this year from all of our stakeholders: our neighbors at Vale do Jequitinhonha, our Federal Government of Brazil, our State Government of Minas Gerais, our customers, BNDES, our shareholders. Sigma Lithium’s accomplishments this year would not have been possible without you. In 2025, we are well-positioned to exceed expectations and bring continued growth and shared prosperity to our region”.

ABOUT SIGMA LITHIUM
Sigma Lithium (TSXV/NASDAQ: SGML, BVMF: S2GM34) is a leading global lithium producer dedicated to powering the next generation of electric vehicle batteries with carbon-neutral, socially and environmentally sustainable chemical-grade lithium concentrate.

Sigma Lithium is one of the world’s largest lithium producers. The Company operates at the forefront of environmental and social sustainability in the electric vehicle battery materials supply chain at its Grota do Cirilo Operation in Brazil. Here, Sigma produces Quintuple Zero Green Lithium at its state-of-the-art Greentech lithium beneficiation plant, delivering net zero carbon lithium, produced with zero carbon intensive energy, zero potable water, zero toxic chemicals and zero tailings dams.

Phase 1 of the Company’s operations entered commercial production in the second quarter of 2023. The Company has issued a Final Investment Decision, formally approving construction to double capacity to 520,000 tonnes of lithium concentrate through the addition of a Phase 2 expansion of its Greentech Plant.

For more information about Sigma Lithium, visit https://www.sigmalithiumresources.com/

Sigma Lithium
LinkedIn: Sigma Lithium
Instagram: @sigmalithium
X (Twitter): @SigmaLithium

FORWARD-LOOKING STATEMENTS

This news release includes certain “forward-looking information” under applicable Canadian and U.S. securities legislation, including but not limited to statements relating to timing and costs related to the general business and operational outlook of the Company, the environmental footprint of tailings and positive ecosystem impact relating thereto, donation and upcycling of tailings, timing and quantities relating to tailings and Green Lithium, achievements and projections relating to the Zero Tailings strategy, achievement of ramp-up volumes, production estimates and the operational status of the Groto do Cirilo Project, and other forward-looking information. All statements that address future plans, activities, events, estimates, expectations or developments that the Company believes, expects or anticipates will or may occur is forward-looking information, including statements regarding the potential development of mineral resources and mineral reserves which may or may not occur. Forward-looking information contained herein is based on certain assumptions regarding, among other things: general economic and political conditions; the stable and supportive legislative, regulatory and community environment in Brazil; demand for lithium, including that such demand is supported by growth in the electric vehicle market; the Company’s market position and future financial and operating performance; the Company’s estimates of mineral resources and mineral reserves, including whether mineral resources will ever be developed into mineral reserves; and the Company’s ability to operate its mineral projects including that the Company will not experience any materials or equipment shortages, any labour or service provider outages or delays or any technical issues. Although management believes that the assumptions and expectations reflected in the forward-looking information are reasonable, there can be no assurance that these assumptions and expectations will prove to be correct. Forward-looking information inherently involves and is subject to risks and uncertainties, including but not limited to that the market prices for lithium may not remain at current levels; and the market for electric vehicles and other large format batteries currently has limited market share and no assurances can be given for the rate at which this market will develop, if at all, which could affect the success of the Company and its ability to develop lithium operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, except as required by law. For more information on the risks, uncertainties and assumptions that could cause our actual results to differ from current expectations, please refer to the current annual information form of the Company and other public filings available under the Company’s profile at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sigma-lithium-exceeds-4q2024-targets-with-75-000t-of-quintuple-zero-green-lithium-produced-positioned-to-surpass-270-000t-in-2025–302340413.html

SOURCE Sigma Lithium Corporation

Continue Reading

Trending